Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl W Mollison

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Prostaglandins & Other Lipid Mediators|May 8, 2007
Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoidsPaul Rubin, Karl W Mollison
Transplant International : Official Journal of the European Society for Organ Transplantation|January 22, 2004
Preliminary in vivo pharmacokinetic and pharmacodynamic evaluation of a novel calcineurin-independent inhibitor of NFATTudor Bîrsan, Camille Dambrin, Kennan C Marsh, et al.
Cellular Immunology|November 12, 2002
T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BICDeanna Haasch, Yung-Wu Chen, Regina M Reilly, et al.
Journal of Cardiovascular Pharmacology|April 18, 2007
Zotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppressionYung-Wu Chen, Morey L Smith, Michael Sheets, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2005
Rapamycin analogs with reduced systemic exposureRolf Wagner, Karl W Mollison, Luping Liu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Prostaglandins & Other Lipid Mediators|May 8, 2007
Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoidsPaul Rubin, Karl W Mollison
Transplant International : Official Journal of the European Society for Organ Transplantation|January 22, 2004
Preliminary in vivo pharmacokinetic and pharmacodynamic evaluation of a novel calcineurin-independent inhibitor of NFATTudor Bîrsan, Camille Dambrin, Kennan C Marsh, et al.
Cellular Immunology|November 12, 2002
T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BICDeanna Haasch, Yung-Wu Chen, Regina M Reilly, et al.
Journal of Cardiovascular Pharmacology|April 18, 2007
Zotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppressionYung-Wu Chen, Morey L Smith, Michael Sheets, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2005
Rapamycin analogs with reduced systemic exposureRolf Wagner, Karl W Mollison, Luping Liu, et al.
Pageof 1